AVITA Medical, Inc.
RCEL
$10.25
$0.181.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.83% | 28.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.83% | 28.63% | |||
| Cost of Revenue | -28.53% | 51.11% | |||
| Gross Profit | -1.41% | 25.01% | |||
| SG&A Expenses | -14.15% | 3.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.96% | 8.29% | |||
| Operating Income | 27.88% | 11.52% | |||
| Income Before Tax | 28.73% | -5.68% | |||
| Income Tax Expenses | 167.86% | -184.85% | |||
| Earnings from Continuing Operations | 28.49% | -5.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.49% | -5.28% | |||
| EBIT | 27.88% | 11.52% | |||
| EBITDA | 29.25% | 12.36% | |||
| EPS Basic | 28.94% | -4.38% | |||
| Normalized Basic EPS | 23.85% | 1.56% | |||
| EPS Diluted | 28.94% | -4.38% | |||
| Normalized Diluted EPS | 23.85% | 1.56% | |||
| Average Basic Shares Outstanding | 0.62% | 0.87% | |||
| Average Diluted Shares Outstanding | 0.62% | 0.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||